Filing Details
- Accession Number:
- 0001209191-10-029468
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-20 13:00:00
- Reporting Period:
- 2010-05-20
- Filing Date:
- 2010-05-20
- Accepted Time:
- 2010-05-20 19:50:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1458451 | Scott Seiwert | 3280 Bayshore Blvd. Brisbane CA 94005 | Svp, Rsearch/ Preclinical Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-05-20 | 417 | $9.75 | 23,666 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reporting person sold the noted securities in connection with the vesting of 417 shares on 5/17/10 (which represents a portion of the previously reported equity incentive grant made on 5/15/2007).